Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
US9493826B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9493826-B2 |
| Application number | US-201414177190-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 10, 2014 |
| Priority date | Mar 24, 2009 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are devices comprising multivolume analysis regions, the devices being capable of supporting amplification, detection, and other processes. Also provided are related methods of detecting or estimating the presence nucleic acids, viral levels, and other biological markers of interest.
Opening claim text (preview).
What is claimed is: 1. A method of binary quantification of nucleic acids in a sample, comprising: a. providing a microfluidic device comprising a first substrate comprising a first population of areas and a second substrate comprising a second population of areas; b. partitioning a sample comprising nucleic acid molecules into said first and second populations of areas in said microfluidic device by exerting the sample through a conduit in fluidic communication with each area of the first population of areas and each area of the second population of areas via a continuous fluidic pathway within said first and second substrates, such that a plurality of said first and second populations of areas each comprise only one nucleic acid molecule; c. loading nucleic acid amplification reagents into said microfluidic device; d. effecting relative motion between the first substrate and the second substrate, thereby isolating the first population of areas from the second population of areas; and e. conducting a nucleic acid amplification reaction in said microfluidic device in both said first and second populations of areas, wherein during said nucleic acid amplification reaction the temperature of said sample and the temperature of said nucleic acid amplification reagents remain within 10° C. of their temperature at the beginning of said nucleic acid amplification reaction. 2. The method of claim 1 , wherein said nucleic acid amplification reaction comprises loop mediated isothermal amplification. 3. The method of claim 1 , wherein said nucleic acid amplification reaction comprises reverse transcription loop mediated isothermal amplification. 4. The method of claim 1 , wherein said nucleic acid amplification reaction comprises nucleic acid sequence based amplification. 5. The method of claim 1 , wherein said nucleic acid amplification reaction comprises sequence-specific polymerase chain reaction. 6. The method of claim 1 , wherein said nucleic acid amplification reaction comprises transcription mediated amplification. 7. The method of claim 1 , wherein said nucleic acid amplification reaction comprises transcription associated amplification. 8. The method of claim 1 , wherein said nucleic acid amplification reaction comprises reverse transcription recombinase polymerase amplification. 9. The method of claim 1 , wherein said nucleic acid amplification reaction comprises strand displacement amplification. 10. The method of claim 1 , wherein said nucleic acid amplification reaction comprises signal mediated amplification of RNA technology. 11. The method of claim 1 , wherein said nucleic acid amplification reaction comprises cyclic enzymatic amplification method. 12. The method of claim 1 , wherein said nucleic acid amplification reaction comprises isothermal target and signaling probe amplification. 13. The method of claim 1 , wherein said nucleic acid amplification reaction comprises ligase chain reaction. 14. The method of claim 1 , wherein said microfluidic device comprises a heat control component.
Quantitative amplification · CPC title
being a microfluidic device · CPC title
sliding valves · CPC title
rotary valves · CPC title
Disc shape · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.